Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Research Article

Clinical Assessment of Autonomic Function in Fibromyalgia by the Refined and Abbreviated Composite Autonomic Symptom Score (COMPASS 31): A Case-Controlled Study

Author(s): Basant K. Puri* and Gary S. Lee

Volume 17, Issue 1, 2022

Published on: 11 June, 2021

Page: [53 - 57] Pages: 5

DOI: 10.2174/1574887116666210612033002

Price: $65

Abstract

Background: It has been shown that autonomic dysfunction in fibromyalgia can be assessed by the Composite Autonomic Symptom Score (COMPASS) questionnaire. More recently, a refined and much abbreviated 31-item version of the questionnaire has been developed, the COMPASS 31.

Objectives: First, to determine whether the COMPASS 31 can assess changes in autonomic function in fibromyalgia. Second, to assess whether the COMPASS 31 values in fibromyalgia patients are positively correlated with scores on the Revised Fibromyalgia Impact Questionnaire (FIQR).

Methods: A cross-sectional, case-controlled study was carried out with 25 fibromyalgia patients and 26 healthy controls.

Results: The two groups were matched for age, sex and ethnicity, but not for body mass index (BMI). The total mean (standard error) COMPASS 31 for the fibromyalgia patients, 37.2 (1.8), differentiated the patients from the controls (9.5 (1.4); p < 0.00000001). The scores were greater in the fibromyalgia patients across all COMPASS 31 autonomic domains, namely orthostatic intolerance (p < 0.00000001), and vasomotor (p < 0.0001), secretomotor (p < 0.000001), gastrointestinal (p < 0.000001), bladder (p < 0.00001) and pupillomotor functions (p < 0.00000001). The total COMPASS 31 values were positively correlated with FIQR scores (rs = 0.45, p < 0.05). General linear modelling of the COMPASS 31 scores showed that only group status (fibromyalgia or control) was significant (p = 3.4 × 10-16), with age, sex and BMI being non-significant.

Conclusion: This study confirms that non-pain autonomic dysfunction symptoms occur in fibromyalgia and can be assessed with the COMPASS 31.

Keywords: Autonomic dysfunction, fibromyalgia, COMPASS 31, FIQR, autonomic nervous system, case-controlled study.

Graphical Abstract
[1]
Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014; 311(15): 1547-55.
[http://dx.doi.org/10.1001/jama.2014.3266] [PMID: 24737367]
[2]
Solano C, Martinez A, Becerril L, et al. Autonomic dysfunction in fibromyalgia assessed by the Composite Autonomic Symptoms Scale (COMPASS). J Clin Rheumatol 2009; 15(4): 172-6.
[http://dx.doi.org/10.1097/RHU.0b013e3181a1083d] [PMID: 19342959]
[3]
Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O’Brien PC, Low PA. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999; 52(3): 523-8.
[http://dx.doi.org/10.1212/WNL.52.3.523] [PMID: 10025781]
[4]
Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991; 18(5): 728-33.
[PMID: 1865419]
[5]
Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 2012; 87(12): 1196-201.
[http://dx.doi.org/10.1016/j.mayocp.2012.10.013] [PMID: 23218087]
[6]
Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11(4): R120.
[http://dx.doi.org/10.1186/ar2783] [PMID: 19664287]
[7]
Kang JH, Kim JK, Hong SH, Lee CH, Choi BY. Heart rate variability for quantification of autonomic dysfunction in fibromyalgia. Ann Rehabil Med 2016; 40(2): 301-9.
[http://dx.doi.org/10.5535/arm.2016.40.2.301] [PMID: 27152281]
[8]
Rizzi M, Atzeni F, Airoldi A, et al. Impaired lung transfer factor in fibromyalgia syndrome. Clin Exp Rheumatol 2016; 34(2)(Suppl. 96): S114-9.
[PMID: 27157396]
[9]
Ramírez M, Guerra-Juárez A, Miyake D-Y, et al. Correlation between corneal nerve density and symptoms of small fiber neuropathy in patients with fibromyalgia: the confounding role of severe anxiety or depression. J Clin Rheumatol in press
[PMID: 33044388]
[10]
Martínez-Lavín M, Martínez-Martínez L-A, Reyes-Loyola P. HPV vaccination syndrome. A questionnaire-based study. Clin Rheumatol 2015; 34(11): 1981-3.
[http://dx.doi.org/10.1007/s10067-015-3070-3] [PMID: 26354426]
[11]
Wolfe F, Smythe HA, Yunus MB, et al. The american college of rheumatology 1990 criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arthritis Rheum 1990; 33(2): 160-72.
[http://dx.doi.org/10.1002/art.1780330203] [PMID: 2306288]
[12]
Wolfe F, Clauw DJ, Fitzcharles M-A, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46(3): 319-29.
[http://dx.doi.org/10.1016/j.semarthrit.2016.08.012] [PMID: 27916278]
[13]
R Core Team.R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing 2017.
[14]
JASP Team. JASP (Version 014). University of Amsterdam 2020.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy